fullerene c60 has been researched along with 2,3-diphosphoglycerate in 1 studies
*2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508) [MeSH]
*2,3-Diphosphoglycerate: A highly anionic organic phosphate which is present in human red blood cells at about the same molar ratio as hemoglobin. It binds to deoxyhemoglobin but not the oxygenated form, therefore diminishing the oxygen affinity of hemoglobin. This is essential in enabling hemoglobin to unload oxygen in tissue capillaries. It is also an intermediate in the conversion of 3-phosphoglycerate to 2-phosphoglycerate by phosphoglycerate mutase (EC 5.4.2.1). (From Stryer Biochemistry, 4th ed, p160; Enzyme Nomenclature, 1992, p508) [MeSH]
| Studies (fullerene c60) | Trials (fullerene c60) | Recent Studies (post-2010) (fullerene c60) | Studies (2,3-diphosphoglycerate) | Trials (2,3-diphosphoglycerate) | Recent Studies (post-2010) (2,3-diphosphoglycerate) |
|---|---|---|---|---|---|
| 3,806 | 5 | 2,170 | 1,418 | 39 | 117 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abdollahi, M; Baeeri, M; Hassani, S; Hassanzadeh, G; Hosseini, A; Kuznetsov, DA; Rezayat, SM; Sharifzadeh, M; Shetab-Bushehri, V | 1 |
1 other study(ies) available for fullerene c60 and 2,3-diphosphoglycerate
| Article | Year |
|---|---|
Benefit of magnesium-25 carrying porphyrin-fullerene nanoparticles in experimental diabetic neuropathy.
Topics: 2,3-Diphosphoglycerate; Adenosine Diphosphate; Adenosine Triphosphate; Animals; Diabetic Neuropathies; Drug Delivery Systems; Fullerenes; Ganglia, Spinal; Humans; Isotopes; Magnesium; Male; Nanomedicine; Nanoparticles; Oxidative Stress; Porphyrins; Rats; Rats, Wistar | 2010 |